aTyr Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell aTyr Pharma and other ETFs, options, and stocks.About ATYR
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1.
CEOSanjay S. Shukla
CEOSanjay S. Shukla
Employees59
Employees59
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2005
Founded2005
Employees59
Employees59
ATYR Key Statistics
Market cap81.20M
Market cap81.20M
Price-Earnings ratio-0.99
Price-Earnings ratio-0.99
Dividend yield—
Dividend yield—
Average volume2.63M
Average volume2.63M
High today$0.8596
High today$0.8596
Low today$0.7524
Low today$0.7524
Open price$0.7689
Open price$0.7689
Volume3.23M
Volume3.23M
52 Week high$7.29
52 Week high$7.29
52 Week low$0.64
52 Week low$0.64
Stock Snapshot
As of today, aTyr Pharma(ATYR) shares are valued at $0.82. The company's market cap stands at 81.2M, with a P/E ratio of -0.99.
As of 2025-12-05, aTyr Pharma(ATYR) stock has fluctuated between $0.75 and $0.86. The current price stands at $0.82, placing the stock +9.5% above today's low and -4.2% off the high.
aTyr Pharma(ATYR) shares are trading with a volume of 3.23M, against a daily average of 2.63M.
During the past year, aTyr Pharma(ATYR) stock moved between $0.64 at its lowest and $7.29 at its peak.
During the past year, aTyr Pharma(ATYR) stock moved between $0.64 at its lowest and $7.29 at its peak.
Analyst ratings
70%
of 10 ratingsBuy
30%
Hold
70%
Sell
0%
People also own
Based on the portfolios of people who own ATYR. This list is generated using Robinhood data, and it’s not a recommendation.